Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 10.22 is 29% below its 5-year average of 14.48, near the low end of its 5-year range (8.99–28.07).
As of the fiscal period ended Tuesday, June 30, 2026. 20.36% below its 12-month average of 12.83.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 10.22.
CURRENT RATIO
10.22
CURRENT RATIO AVG TTM
12.83
CURRENT RATIO AVG 3Y
12.17
CURRENT RATIO AVG 5Y
14.48
CURRENT RATIO AVG 10Y
11.39
CURRENT RATIO AVG 15Y
9.18
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-20.36%
CURRENT VS 3Y AVG
-16.02%
CURRENT VS 5Y AVG
-29.42%
CURRENT VS 10Y AVG
-10.27%
CURRENT VS 15Y AVG
+11.34%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.17
median of 462 covered companies
CURRENT VS SECTOR MEDIAN
+222.42%
vs the sector median at left
Agios Pharmaceuticals, Inc.
Market Cap
$1.87B
Current Ratio
10.22
TTM Avg
12.83
3Y Avg
12.17
5Y Avg
14.48
Market Cap
$1.78B
Current Ratio
8.30
TTM Avg
3.78
3Y Avg
3.78
5Y Avg
3.78
Market Cap
$1.78B
Current Ratio
6.65
TTM Avg
5.42
3Y Avg
7.28
5Y Avg
7.47
Market Cap
$1.96B
Current Ratio
3.84
TTM Avg
3.30
3Y Avg
3.38
5Y Avg
3.69
Market Cap
$1.76B
Current Ratio
1.70
TTM Avg
1.79
3Y Avg
1.95
5Y Avg
2.14
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Agios Pharmaceuticals, Inc. (AGIO) | $1.87B | 10.22 | 12.83 | 12.17 | 14.48 |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | 9.69 | 5.24 | 4.11 | 4.46 |
| Astrana Health, Inc. (ASTH)vs › | $1.83B | 1.23 | 1.57 | 2.04 | 2.44 |
| Generate Biomedicines, Inc. (GENB)vs › | $1.78B | 8.30 | 3.78 | 3.78 | 3.78 |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.78B | 6.65 | 5.42 | 7.28 | 7.47 |
| Absci Corporation (ABSI)vs › | $1.95B | 10.63 | 5.62 | 5.37 | 6.14 |
| Establishment Labs Holdings Inc. (ESTA)vs › | $1.96B | 3.84 | 3.30 | 3.38 | 3.69 |
| Alignment Healthcare, Inc. (ALHC)vs › | $1.76B | 1.70 | 1.79 | 1.95 | 2.14 |
| Azenta, Inc. (AZTA)vs › | $1.97B | 2.50 | 3.53 | 6.11 | 4.96 |
| AxoGen, Inc. (AXGN)vs › | $2.00B | 6.60 | 4.18 | 3.84 | 4.49 |
Current Ratio
10.22
Quick Ratio
9.79
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 10.22 |
| 2026-03-31 | 14.19 |
| 2025-12-31 | 11.46 |
| 2025-09-30 | 13.82 |
| 2025-06-30 | 14.48 |
| 2025-03-31 | 18.50 |
| 2024-12-31 | 11.90 |
| 2024-09-30 | 8.99 |
| 2024-06-30 | 10.09 |
| 2024-03-31 | 12.84 |
| 2023-12-31 | 12.27 |
| 2023-09-30 | 12.06 |
| 2023-06-30 | 13.73 |
| 2023-03-31 | 17.55 |
| 2022-12-31 | 13.30 |
| 2022-09-30 | 14.65 |
| 2022-06-30 | 17.98 |
| 2022-03-31 | 21.30 |
| 2021-12-31 | 17.79 |
| 2021-09-30 | 22.55 |
| 2021-06-30 | 28.07 |
| 2021-03-31 | 24.40 |
| 2020-12-31 | 6.74 |
| 2020-09-30 | 9.59 |
| 2020-06-30 | 13.15 |
| 2020-03-31 | 8.41 |
| 2019-12-31 | 6.59 |
| 2019-09-30 | 5.30 |
| 2019-06-30 | 5.96 |
| 2019-03-31 | 6.89 |
| 2018-12-31 | 6.56 |
| 2018-09-30 | 8.21 |
| 2018-06-30 | 8.88 |
| 2018-03-31 | 10.75 |
| 2017-12-31 | 4.69 |
| 2017-09-30 | 6.00 |
| 2017-06-30 | 6.46 |
| 2017-03-31 | 6.15 |
| 2016-12-31 | 6.33 |
| 2016-09-30 | 7.70 |
| 2016-06-30 | 7.20 |
| 2016-03-31 | 7.31 |
| 2015-12-31 | 6.38 |
| 2015-09-30 | 7.47 |
| 2015-06-30 | 8.63 |
| 2015-03-31 | 10.01 |
| 2014-12-31 | 5.89 |
| 2014-09-30 | 7.06 |
| 2014-06-30 | 5.49 |
| 2014-03-31 | 5.06 |
| 2013-12-31 | 4.60 |
| 2013-09-30 | 5.32 |
| 2013-06-30 | 2.77 |
| 2013-03-31 | 3.20 |
| 2012-12-31 | 3.71 |
| 2012-09-30 | 0.00 |
| 2012-06-30 | 0.00 |
| 2012-03-31 | 0.00 |
